skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

​Drive commercial success

drive commerical success pharma intelligence

We need to continually evaluate our disease strategy, comparing it against the competition to discern gaps in our portfolio. Given our internal capabilities, we need access to information to best inform us as to whether we build or buy.

  • We need the right data and analysis to support us in determining our portfolios' net present value.
  • We need to continually assess each internal candidate against our competitors' pipeline.
  • Our small team needs to be able to identify early clinical stage drugs that address promising new molecular targets. 

 

Our Portfolio Strategy solutions arm you with timely and accurate intelligence you can act on, including:

  • A wealth of expert insights gathered by our global team of more than 60 journalists and over 200 specialist analysts
  • The most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends
  • Sales forecasts for early phase pipeline candidates and patient-based sales forecasts from surveys of more than 200 physicians per indication
  • Country-specific treatment algorithms and reimbursement scenarios
  • Comprehensive and timely market research reports to help you understand macro trends and synthesize key insights so the “big picture” always informs your commercial decisions - Ask-the-Analyst™ service that put you in direct contact with our global analyst team

Relevant products

video-thumb-sample

Pharmapremia: Benchmark better and optimize your drug development pipeline

Using a peer-reviewed methodology that provides robust, unbiased drug phase success rates and timeline metrics by treatment indication, Pharmapremia enables you to make strong, informed decisions about your drug development pipeline.

Key benefits:

  • Manage risks in your portfolio
  • Analyze clinical and regulatory success factors
  • Create meaningful benchmarks critical to success
video-thumb-sample

Datamonitor Healthcare

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions
video-thumb-sample

In Vivo

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

  • Cutting edge thought leadership
  • Expert analysis
  • Hear from news makers

Pharma Intelligence latest insights

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: